ID: ALA2115566

Max Phase: Preclinical

Molecular Formula: C6H10O3

Molecular Weight: 130.14

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@@H]1OC=C[C@@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C6H10O3/c1-4-6(8)5(7)2-3-9-4/h2-8H,1H3/t4-,5+,6+/m0/s1

Standard InChI Key:  ZPKHLHZFXAQVMQ-KVQBGUIXSA-N

Associated Targets(Human)

Alpha-L-fucosidase I 304 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 130.14Molecular Weight (Monoisotopic): 130.0630AlogP: -0.36#Rotatable Bonds: 0
Polar Surface Area: 49.69Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.04CX Basic pKa: CX LogP: -0.59CX LogD: -0.59
Aromatic Rings: 0Heavy Atoms: 9QED Weighted: 0.47Np Likeness Score: 2.55

References

1. Dumas DP, Kajimoto T, Liu KK, Wong C, Berkowitz DB, Danieshefsky SJ.  (1992)  Azasugar and glycal inhibitors of -L-fucosidase,  (1): [10.1016/S0960-894X(00)80649-6]

Source